Research location
Chelmsford
Essex, United Kingdom
Advertisement
Research activity in Chelmsford
Essex, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 28 trials and 28 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Chelmsford
28 linked trials · page 1 of 1A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 1 site observation
RECRUITING
GentleCath™ for Men Intermittent Catheter With FeelClean™ TechnologyNCT05470751 · 2023-02-02 · 1 site observation
COMPLETED
A Study of Surgical Interventions in Fistulizing ConditionsNCT04940611 · 2021-08-05 · 1 site observation
COMPLETED
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisNCT03915964 · 2019-04-25 · 1 site observation
COMPLETED
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionNCT03850782 · 2019-02-28 · 1 site observation
COMPLETED
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart FailureNCT03152552 · 2017-07-25 · 1 site observation
TERMINATED
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
Comparison of PEAK PlasmaBlade™ to Conventional Diathermy in Abdominal Based Free Flap Breast ReconstructionNCT04350411 · 2016-10-31 · 1 site observation
COMPLETED
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 1 site observation
COMPLETED
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)NCT02776072 · 2016-05-01 · 1 site observation
COMPLETED
Malignant Mesothelioma - Can we Improve Quality of LifeNCT03068117 · 2014-04-03 · 1 site observation
COMPLETED
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)NCT01562028 · 2012-06-01 · 1 site observation
COMPLETED
Study of Immunotherapy to Treat Advanced Prostate CancerNCT00861614 · 2009-05-01 · 1 site observation
COMPLETED
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast CancerNCT00777101 · 2009-02-04 · 1 site observation
COMPLETED
Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast CancerNCT00767520 · 2009-02-01 · 1 site observation
COMPLETED
Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerNCT00706030 · 2008-04-29 · 1 site observation
COMPLETED
A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerNCT00550173 · 2007-11-01 · 1 site observation
COMPLETED
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast CancerNCT00370552 · 2007-03-01 · 1 site observation
COMPLETED
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerNCT00435409 · 2007-02-01 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung CancerNCT00363415 · 2006-08-01 · 1 site observation
COMPLETED
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNCT00338247 · 2006-07-01 · 1 site observation
APPROVED_FOR_MARKETING
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerNCT00347919 · 2006-07-01 · 1 site observation
COMPLETED
Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa StudyNCT00255463 · 2004-01-01 · 1 site observation
COMPLETED
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerNCT00073528 · 2003-12-09 · 1 site observation
COMPLETED
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerNCT00080301 · 2003-09-01 · 1 site observation
COMPLETED
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerNCT00276276 · 2000-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.